International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2018 - Volume 22, Number 5
View All Articles in Issue

Page(s): 409

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, fluoxetine, topical preparation, transdermal absorption, anxiety, selective serotonin reuptake inhibitor, SSRI

Related Categories: EXCIPIENTS, FORMULATIONS, MENTAL HEALTH, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	Sep/Oct 2018 Pg. 409
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E	May/Jun 2017 Pg. 242-246
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Fields Shannon W	Nov/Dec 2006 Pg. 418
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita	May/Jun 2014 Pg. 253-255
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth	May/Jun 2014 Pg. 256-261
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 73
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 244
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Lehman Paul A, Raney Sam G	May/Jun 2012 Pg. 248-252
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Allen Loyd V Jr	May/Jun 2003 Pg. 180-183
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D	May/Jun 2005 Pg. 242-246
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 245
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2012 Pg. 62-63
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Allen Loyd V Jr	Jul/Aug 2021 Pg. 322
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Wynn Tom, Goetsch Daniel	May/Jun 2011 Pg. 200-203
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Arnold John J, Asbill Scott	Nov/Dec 2009 Pg. 569-571
Return to Top